Aquilus Pharmaceuticals

LEADING THE WAY IN NEURODEGENERATIVE DISEASE TREATMENTS

Aquilus Pharmaceuticals (Aquilus) is a biotech company focused on the treatment of neurodegenerative diseases, in particular Amyotrophic Lateral Sclerosis (ALS). Our dedicated team is committed to developing innovative therapies to address the unmet medical needs of patients suffering from these debilitating conditions. We are driven by a passion to make a meaningful difference in the lives of individuals affected by neurodegenerative diseases. At Aquilus Pharmaceuticals, we strive to stand out in the field of biotechnology by leveraging cutting-edge research and a patient-centric approach to drug development.